Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma

Clinical trial NCT04102150 · COMPLETED

Trial details

NCT number: NCT04102150
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult T-cell Leukemia/Lymphoma

Start date: 2019-11-21
Primary completion: 2021-04-24
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.